All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
To achieve a successful advancement in personalized CAR therapeutics for the treatment of cancers, Creative Biolabs provides CellRapeutics™ CAR Clinical Trials service. Since the CAR therapeutics holds great promise to improving cancer patients'health, we strive to move these novel therapeutics into clinical trials based on our years of experience in CAR technology, uncompromising quality standards and unbeatable timelines. For each project, once the preclinical animal models study for safety and efficacy test is complete and ready for clinical trials, Creative Biolabs assembles a strong team with experienced Ph.D level scientists and clinicians, well trained technicians, responsible project managers just in order to deliver the most suitable service according to your budget, timeline, and specific requirements.
To speed up the development of CAR therapeutics in clinical trials, we provide one-stop, full spectrum service to deliver the most efficient and economic outcomes.
Service & Solutions
• Review of preclinical testing
• Study design and protocol writing
• Ethics & Regulatory
• Project management
• Physician management
• Clinical operations
• Patient enrollment
• Patient treatment
• Patient follow-up
• Data management
• Study summary
• Biostatistics & medical writing
• QA&QC
To discuss your CellRapeutics™ CAR Clinical Trials demands or to request a proposal, please contact us by .
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION